While GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are not FDA-approved for joint pain treatment, emerging evidence suggests they may provide indirect benefits through substantial weight loss
Incretin mimetics provide a pharmacological stimulus to insulin secretion and elicit other GLP-1-receptor-mediated activity as drugs, but are typically introduced at much higher concentrations compared with physiological levels of GLP-1 [65, 66]
Pediatr Diabetes 11(1):411
The extra stepsprescription, medical consultation, licensed pharmacyaren't obstacles
It may also be possible to use small molecule activators of ferroptosis to selectively eliminate cancer cells with mutations in the RAS-RAF-MEK pathway, although this remains controversial [6, 12, 13]
Do stimulant-free pre-workouts work